Infinity Bio Overview
- Year Founded
-
2023
- Status
-
Private
- Employees
-
23
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$8M
- Investors
-
6
Infinity Bio General Information
Description
Operator of an antibody profiling company intended to accelerate various discoveries. The company's platform utilizes libraries of proteins and peptides and a novel self-assembling system to comprehensively analyze an individual's antibody response, enabling researchers to understand the immune status of individuals or groups and identify immune-related patterns.
Contact Information
Website
www.infinitybio.comCorporate Office
- 6200 Seaforth Street
- Suite A
- Baltimore, MD 21224
- United States
Corporate Office
- 6200 Seaforth Street
- Suite A
- Baltimore, MD 21224
- United States
Infinity Bio Timeline
Infinity Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Early Stage VC (Series A) | 01-Oct-2025 | $8M | Completed | Generating Revenue | ||
| 2. Seed Round | 23-Jun-2023 | Completed | Generating Revenue | |||
| 1. Accelerator/Incubator | Completed | Generating Revenue |
Infinity Bio Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-2 | ||||||||
| Series A-1 | ||||||||
| Seed | 8,442,871 | $0.000100 | $0.53 | $0.53 | 1x | $0.53 | 17.69% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Infinity Bio Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Infinity Bio Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Infinity Bio Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Illumina Ventures | Venture Capital | Minority | ||
| TCP Venture Capital | Venture Capital | Minority | ||
| TEDCO | Venture Capital | Minority | ||
| Blackbird BioVentures | Venture Capital | Minority | ||
| PTX Capital | Venture Capital | Minority |
Infinity Bio Acquisitions (1)
Infinity Bio’s most recent deal was a Merger/Acquisition with Serimmune. The deal was made on 18-Jun-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Serimmune | 18-Jun-2025 | Merger/Acquisition | Biotechnology |
Infinity Bio FAQs
-
When was Infinity Bio founded?
Infinity Bio was founded in 2023.
-
Where is Infinity Bio headquartered?
Infinity Bio is headquartered in Baltimore, MD.
-
What is the size of Infinity Bio?
Infinity Bio has 23 total employees.
-
What industry is Infinity Bio in?
Infinity Bio’s primary industry is Biotechnology.
-
Is Infinity Bio a private or public company?
Infinity Bio is a Private company.
-
What is the current valuation of Infinity Bio?
The current valuation of Infinity Bio is .
-
What is Infinity Bio’s current revenue?
The current revenue for Infinity Bio is .
-
How much funding has Infinity Bio raised over time?
Infinity Bio has raised $12.5M.
-
Who are Infinity Bio’s investors?
Illumina Ventures, TCP Venture Capital, TEDCO, Blackbird BioVentures, and PTX Capital are 5 of 6 investors who have invested in Infinity Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
